Jiang, H., Zhu, M., Li, Y., & Li, Q. (2019). Association between EGFR exon 19 or exon 21 mutations and survival rates after first-line EGFR-TKI treatment in patients with non-small cell lung cancer. Mol Clin Oncol.
Chicago ZitierstilJiang, Haiying, Mei Zhu, Yanfang Li, und Qian Li. "Association between EGFR Exon 19 or Exon 21 Mutations and Survival Rates After First-line EGFR-TKI Treatment in Patients With Non-small Cell Lung Cancer." Mol Clin Oncol 2019.
MLA ZitierstilJiang, Haiying, Mei Zhu, Yanfang Li, und Qian Li. "Association between EGFR Exon 19 or Exon 21 Mutations and Survival Rates After First-line EGFR-TKI Treatment in Patients With Non-small Cell Lung Cancer." Mol Clin Oncol 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.